Charles River Laboratories CRL RMS — Operating Income (Loss)

Other segment segments

Similar metrics at other companies

FLEXRMS — Operating Income (Loss), Adjusted

$152.75M+21.0%

RMBSRSD Member Domain — Segment Operating Income Loss

$155K-97.6%

RBAOperating Segments — Operating Income

$82.54M+34.6%

RMBSOperating Segments — Segment Operating Income Loss

$18.16M+15.3%

ITResearch — Operating Income

$943.43M+5.5%

CSL

CSLCCM — Operating Income (Loss)

$184M-5.5%

Questions, answered.

What is Charles River Laboratories's RMS — operating income (loss)?

Charles River Laboratories (CRL) reported RMS — operating income (loss) of $49.77M in Q1 2026.

How has Charles River Laboratories's RMS — operating income (loss) changed year-over-year?

Charles River Laboratories's RMS — operating income (loss) increased by 14.1% year-over-year, from $43.61M to $49.77M.

What does RMS — operating income (loss) mean?

The profit or loss generated by the segment from its core business operations.

How do you interpret RMS — operating income (loss)?

An increase signifies improved operational performance and profitability, while a decrease indicates margin pressure or operational challenges.

How does RMS — operating income (loss) compare across companies?

Comparable to segment-level operating profit metrics for peer companies in the life sciences and research services industry.